Curative Biotechnology, Inc. Announces Addition of Dr. Nicholas Boulis to Scientific and ...
Company's Clinical Program for CD56 Monoclonal AntibodyDrug Conjugate for Treatment ofGlioblastoma to Benefit from Expertise in Neurobiology |!| Keokuk
Company's Clinical Program for CD56 Monoclonal AntibodyDrug Conjugate for Treatment ofGlioblastoma to Benefit from Expertise in Neurobiology |!| Keokuk